Back to Search Start Over

Ovariectomy disregulates osteoblast and osteoclast formation through the T-cell receptor CD40 ligand.

Authors :
Jau-Yi Li
Tawfeek, Hesham
Bedi, Brahmchetna
Xiaoying Yang
Adams, Jonathan
Gao, Kristy Y.
Zayzafoon, Majd
Neale Weitzmann, M.
Pacifici, Roberto
Source :
Proceedings of the National Academy of Sciences of the United States of America. 1/11/2011, Vol. 108 Issue 2, p768-773. 6p. 1 Diagram, 1 Chart, 2 Graphs.
Publication Year :
2011

Abstract

The bone loss induced by ovariectomy (ovx) has been linked to increased production of osteoclastogenic cytokines by bone marrow cells, including T cells and stromal cells (SCs). It is presently unknown whether regulatory interactions between these lineages contribute to the effects of ovx in bone, however. Here, we show that the T-cell costimulatory molecule CD40 ligand (CD40L) is required for ovx to expand SCs; promote osteoblast proliferation and differentiation; regulate the SC production of the osteoclas- togenic factors macrophage colony-stimulating factor, receptor activator of nuclear factor-κB ligand, and osteoprotegerin; and upregulate osteoclast formation. CD40L is also required for ovx to activate T cells and stimulate their production of TNF. Accordingly, ovx fails to promote bone loss and increase bone resorption in mice depleted of T cells or lacking CD40L. Therefore, cross-talk between T cells and 5Cs mediated by CD40L plays a pivotal role in the disregulation of osteoblastogenesis and osteoclastogenesis induced by ovx. [ABSTRACT FROM AUTHOR]

Details

Language :
English
ISSN :
00278424
Volume :
108
Issue :
2
Database :
Academic Search Index
Journal :
Proceedings of the National Academy of Sciences of the United States of America
Publication Type :
Academic Journal
Accession number :
58794788
Full Text :
https://doi.org/10.1073/pnas.1013492108